PMID: 3214464Aug 1, 1988Paper

Familial hypercholesterolemia and apolipoprotein E4

Atherosclerosis
M EtoK Ishii

Abstract

The purpose of this study was to elucidate the relationship between two genetic factors associated with raised blood cholesterol, i.e. familial hypercholesterolemia (FH) and apolipoprotein (apo) E4. A group of 50 unrelated heterozygous FH patients aged 33-71 years were studied together with 129 normolipidemic subjects. A significantly higher frequency of apo E4 phenotypes was found in FH patients (30.0%) than in normolipidemic subjects (15.5%). FH patients were divided into two groups with and without apo E4. Plasma total cholesterol (Chol) and triglyceride (TG) levels were significantly higher, and plasma low density lipoprotein-cholesterol (LDL-Chol) level tended to be higher in FH patients with apo E4 than in those without apo E4. In addition, the prevalence of ischemic heart disease (IHD) was significantly higher in FH patients with apo E4 (73.3%) than in those without apo E4 (31.4%). No significant difference was noted in age and in the prevalence of obesity, diabetes, hypertension and smoking between the FH groups with and without apo E4. These results suggest that apo E4 is associated with higher levels of total Chol and TG and, at least in part, contributes to the predisposition to IHD in FH.

References

Nov 1, 1977·Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics·H MabuchiT Takegoshi
Jan 1, 1987·Genetic Epidemiology·R A Hegele, J L Breslow
Aug 1, 1987·The Journal of Clinical Investigation·Y A KesäniemiT A Miettinen
Jan 1, 1986·The Tohoku Journal of Experimental Medicine·M EtoK Ishii
Feb 1, 1987·Atherosclerosis·H Simonen, T A Miettinen
Jun 30, 1985·Clinica Chimica Acta; International Journal of Clinical Chemistry·M EtoK Ishii
Jan 1, 1968·Monograph Series·G A Rose, H Blackburn
Dec 1, 1983·The Tohoku Journal of Experimental Medicine·J KoizumiR Takeda
Jan 1, 1984·Human Genetics·G UtermannA Steinmetz
Jan 1, 1984·Human Genetics·G UtermannF Zimmer
Apr 1, 1984·Clinical Genetics·A M Cumming, F W Robertson
Jul 1, 1983·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·H J MenzelG Assmann
Aug 1, 1982·The Journal of Clinical Investigation·G GhiselliH B Brewer

❮ Previous
Next ❯

Citations

Jan 1, 2002·Indian Journal of Clinical Biochemistry : IJCB·Tester F AshavaidKappiareth G Nair
Jan 19, 2013·Current Atherosclerosis Reports·Christiane Reitz
Nov 28, 1992·Lancet·J P O'Malley, D R Illingworth
Jul 17, 2001·Clinical Genetics·J U Brorholt-PetersenO Faergeman
Aug 1, 1997·Journal of the American College of Nutrition·D M Dreon, R M Krauss
Jan 8, 2014·The Pan African Medical Journal·Fatiha BenyahyaMohcine Bennani
Aug 11, 2000·Paediatric Drugs·S Tonstad
Oct 11, 2007·Pharmacogenomics·George V Z Dedoussis
Nov 21, 2007·Journal of Clinical Laboratory Analysis·Altaf A KondkarTester F Ashavaid
Jun 8, 2012·Scandinavian Journal of Immunology·A HovlandT E Mollnes
Nov 22, 2005·Lancet Neurology·Leila A ShobabHoward H Feldman
Dec 8, 2005·Mechanisms of Ageing and Development·Magnus SjögrenIngmar Skoog
May 25, 2010·The American Journal of Cardiology·Patrick M MoriartyJames M Backes
May 25, 2006·Journal of Cellular Biochemistry·Sang-Il KimYoung-Gyu Ko
Sep 28, 2014·Experimental Gerontology·Gurdeep Marwarha, Othman Ghribi
Apr 30, 2016·Heart·Mahtab SharifiDevaki Nair
Mar 14, 2012·Mutation Research. Reviews in Mutation Research·Christina SchleckerJörn Lötsch
Oct 1, 1993·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·M J KotzeG A Coetzee
May 1, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·P V KoivistoK Kontula
Mar 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·J S HillP H Pritchard
Aug 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·S TonstadL Ose
Jun 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·J F Graadt van RoggenM J Kotze
Dec 31, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·A F VuorioK Kontula
Oct 20, 2011·Circulation. Cardiovascular Genetics·Jorie VersmissenEric J G Sijbrands
Sep 22, 2018·Clinical Chemistry and Laboratory Medicine : CCLM·L Renee RuhaakChrista M Cobbaert
Oct 1, 1988·Clinical Genetics·M EtoK Ishii
Sep 15, 2005·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Magnus Sjögren, Kaj Blennow
Sep 18, 1997·Annals of Clinical Biochemistry·E B DulyC A Graham
Mar 25, 2020·Trends in Cardiovascular Medicine·Vanessa BianconiUNKNOWN International Lipid Expert Panel (ILEP)
Dec 3, 1999·Archives of Pathology & Laboratory Medicine·N DzimiriZ Halees

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.